Safety profile of belzutifan monotherapy in patients with renal cell carcinoma: A pooled analysis of 4 clinical trials

被引：3

作者：

Choueiri, Toni K. ^{[1
]}

Ghatalia, Pooja ^{[2
]}

de Velasco, Guillermo ^{[3
]}

Albiges, Laurence ^{[4
]}

Burotto, Mauricio ^{[5
]}

Suarez, Cristina ^{[6
]}

Brugarolas, James ^{[7
]}

Iacovelli, Roberto ^{[8
]}

Jalkanen, Katriina ^{[9
]}

Lam, Elaine T. ^{[10
]}

Srinivasan, Ramaprasad ^{[11
]}

Merchan, Jaime ^{[12
]}

Agarwal, Neeraj ^{[13
]}

Iversen, Ane B. ^{[14
]}

Rini, Brian ^{[15
]}

Bauer, Todd M. ^{[16
]}

Gurney, Howard ^{[17
]}

Iliopoulos, Othon ^{[18
,19
]}

Lin, Jianxin ^{[20
]}

Starkopf, Liis ^{[20
]}

Donica, Margarita ^{[20
]}

Gumieniak, Olga ^{[20
]}

Vickery, Donna ^{[20
]}

Liu, Yanfang ^{[20
]}

Perini, Rodolfo F. ^{[20
]}

Powles, Thomas ^{[21
]}

Jonasch, Eric ^{[22
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA USA

[2] Fox Chase Canc Ctr, Philadelphia, PA USA

[3] Univ Hosp 12 Octubre, Madrid, Spain

[4] Inst Gustave Roussy, Med Oncol Dept, Villejuif, France

[5] Bradford Hill Clin Res Ctr, Santiago, Chile

[6] Hosp Univ Vall Dhebron, Vall dHebron Inst Oncol VHIO, Vall dHebron Barcelona Hosp Campus, Barcelona, Spain

[7] Univ Texas Southwestern Med Ctr Dallas, Internal Med Hematol Oncol, Dallas, TX USA

[8] Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy

[9] HUS Helsinki Univ Hosp, Comprehens Canc Ctr, Helsinki, Finland

[10] Univ Colorado Anschutz Med Campus, Univ Colorado Canc Ctr, Aurora, CO USA

[11] NCI, Ctr Canc Res, Bethesda, MD USA

[12] Univ Miami Hosp & Clin, Sylvester Canc Ctr, Canc Res Serv, Oncol, Miami, FL USA

[13] Huntsman Canc Inst, Clin Translat Canc Res Genitourinary Oncol Progra, Salt Lake City, UT USA

[14] Aarhus Univ Hosp, Aarhus, Denmark

[15] Vanderbilt Ingram Canc Ctr, Nashville, OH USA

[16] Greco Hainsworth Ctr Res Tennessee Oncol PLLC, Nashville, TN USA

[17] Macquarie Univ, Oncol, Sydney, NSW, Australia

[18] Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA

[19] Harvard Med Sch, Boston, MA USA

[20] Merck & Co Inc, Rahway, NJ USA

[21] Barts Hlth NHS Trust, St Bartholomews Hosp, London, England

[22] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

来源：

ONCOLOGIST | 2024年 / 29卷

关键词：

Belzutifan; HIF-2a; renal cell carcinoma;

D O I：

10.1093/oncolo/oyae181.004

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：2

共 50 条

[21] Safety and efficacy profile of belzutifan, a hypoxia-inducible factor-2α inhibitor, in patients with renal cell carcinoma: Meta-analysis and systematic review
Shafique, Nouman
Javeed, Zainab
Bajwa, Shammas
Ghaffar-Muhibullah, Umar
Ahmed, Jawad
Zain, Sarmad
Kaur, Navneet
Ghaffar, Ali
Kunwar, Digbijay
Farooqui, Sabeeh
Iqbal, Abdul Ghani
Naqvi, Syed Mujtaba Ali
Qadeer, Abdul
Ehsan, Amna
Shafiq, Iqra
Shafique, Adeena
Rizwan, Umer
Hussain, Rida
Lohana, Abhi
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[22] Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trials
Anne Lynn S. Chang
Sarah T. Arron
Michael R. Migden
James A. Solomon
Simon Yoo
Bann-Mo Day
Edward F. McKenna
Aleksandar Sekulic
Orphanet Journal of Rare Diseases, 11
[23] Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trials
Chang, Anne Lynn S.
Arron, Sarah T.
Migden, Michael R.
Solomon, James A.
Yoo, Simon
Day, Bann-Mo
McKenna, Edward F.
Sekulic, Aleksandar
ORPHANET JOURNAL OF RARE DISEASES, 2016, 11
[24] Clinical efficacy and safety of secukinumab in patients with psoriasis and comorbidities: pooled analysis of 4 phase 3 clinical trials
Gottlieb, Alice B.
Wu, Jashin J.
Griffiths, Christopher E. M.
Marfo, Kwaku
Muscianisi, Elisa
Meng, Xiangyi
Frueh, Jennifer
Lebwohl, Mark
JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (03) : 1482 - 1490
[25] The renal safety profile of fluvastatin: Results of a pooled analysis
Holdaas, Hallvard
Wanner, Christoph
Abletshauser, Claudia
Gimpelewicz, Claudio
Isaacsohn, Jonathan
RENAL FAILURE, 2006, 28 (06) : 487 - 492
[26] Efficacy and safety profile of sunitinib as a first line treatment for advanced/metastatic clear-cell renal cell carcinoma: Pooled analysis of randomized controlled trials.
Haykal, Tarek
Samji, Varun
Zayed, Yazan
Al-Dulaimi, Ragheed
Gakhal, Inderdeep
Bala, Areeg
Sotzen, Jason
Ghamrawi, Ranine
Katato, Khalil
Danish, Rizwan
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[27] Safety profile of temsirolimus in patients with metastatic renal cell carcinoma
Levakov, Ivan
Vojinov, Sasa
Marusic, Goran
Popov, Milan
Levakov, Olivera
Popov, Mladen
Jeremic, Dimitrije
JOURNAL OF BUON, 2016, 21 (06): : 1442 - 1448
[28] Zanubrutinib monotherapy in relapsed/refractory mantle cell lymphoma: a pooled analysis of two clinical trials
Keshu Zhou
Dehui Zou
Jianfeng Zhou
Jianda Hu
Haiyan Yang
Huilai Zhang
Jie Ji
Wei Xu
Jie Jin
Fangfang Lv
Ru Feng
Sujun Gao
Daobin Zhou
Constantine S. Tam
David Simpson
Michael Wang
Tycel J. Phillips
Stephen Opat
Zhiyue Huang
Huafei Lu
Yuqin Song
Yongping Song
Journal of Hematology & Oncology, 14
[29] Zanubrutinib monotherapy in relapsed/refractory mantle cell lymphoma: a pooled analysis of two clinical trials
Zhou, Keshu
Zou, Dehui
Zhou, Jianfeng
Hu, Jianda
Yang, Haiyan
Zhang, Huilai
Ji, Jie
Xu, Wei
Jin, Jie
Lv, Fangfang
Feng, Ru
Gao, Sujun
Zhou, Daobin
Tam, Constantine S.
Simpson, David
Wang, Michael
Phillips, Tycel J.
Opat, Stephen
Huang, Zhiyue
Lu, Huafei
Song, Yuqin
Song, Yongping
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
[30] Long-Term Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma: A Pooled Analysis of Clinical Trials
Tannir, Nizar M.
Figlin, Robert A.
Gore, Martin E.
Michaelson, M. Dror
Motzer, Robert J.
Porta, Camillo
Rini, Brian I.
Hoang, Caroline
Lin, Xun
Escudier, Bernard
CLINICAL GENITOURINARY CANCER, 2018, 16 (01) : 6 - +

← 1 2 3 4 5 →